close

Enter

Log in using OpenID

Chronic Lymphocytic Leukemia Market Insights, Emerging Trends, Growth and Forecasts, 2016-2020

embed
The report covers the present scenario and the growth prospects of the global CLL therapeutics market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded and generic drugs used to treat and p
Hexa Reports
Market Research Reports and Insightful Company Profiles
Global Chronic Lymphocytic Leukemia Market Size, Share,
Costs and Price, Global Insights, Emerging Trends, Growth,
Analysis and Forecasts, 2016-2020
About the Chronic Lymphocytic Leukemia (CLL) Therapeutics Market
Cancer that starts from the hematopoietic stem cells of the bone-marrow is referred to as leukemia.
Leukemia can be chronic or acute depending on the maturity of the cells. In addition, based on the bone
marrow cells from which the cancer starts, leukemia can be categorized as lymphocytic or myeloid.
Hence, leukemia can be broadly classified into four types:
-Acute myeloid (or myelogenous) leukemia (AML)
-Chronic myeloid (or myelogenous) leukemia (CML)
-Acute lymphocytic (or lymphoblastic) leukemia (ALL)
-CLL
Technavio's analysts forecast the global CLL therapeutics market to grow at a CAGR of 19.16% during the
period 2016-2020.
Browse Detail Report With TOC @ http://www.hexareports.com/report/global-chronic-lymphocyticleukemia-market-2016-2020/details
Covered in this report
The report covers the present scenario and the growth prospects of the global CLL therapeutics market
for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of
branded and generic drugs used to treat and prevent CLL. The report also considers the revenues to be
Hexa Reports
Market Research Reports and Insightful Company Profiles
generated from the sales of drugs that are expected to be launched into the market along with the
decline in revenues from the genericization of the marketed drugs during the forecast period.
The market is divided into the following segments based on geography:
-Americas
-APAC
-EMEA
Technavio's report, Global Chronic Lymphocytic Leukemia (CLL) Therapeutics Market 2016-2020, has
been prepared based on an in-depth market analysis with inputs from industry experts. The report
covers the market landscape and its growth prospects over the coming years. The report also includes a
discussion of the Key vendors operating in this market.
Key vendors
-F. Hoffman-La Roche
-AbbVie
-Teva Pharmaceuticals
-Gilead Sciences
-Novartis
-Johnson & Johnson
Other prominent vendors
-Altor BioScience
-Amgen
-Arno Therapeutics
-AstraZeneca
-Bellicum Pharmaceuticals
-Biogen
-BioLineRx
-Boston Biomedical
-Celgene
-Emergent BioSolutions
-Genzyme
-iDD biotech
-Immunomedics
-Infinity Pharmaceuticals
-Innate Pharma
-Karyopharm Therapeutics
-Ligand Pharmaceuticals
-MedImmune
-Merck Sharp & Dohme
-Molecular Templates Inc.
Hexa Reports
Market Research Reports and Insightful Company Profiles
-MorphoSys
-Ono Pharmaceutical
-Portola Pharmaceuticals
-Regeneron Pharmaceuticals
-Sunesis Pharmaceuticals
-TG Therapeutics
-TheraMAB
-XEME Biopharma
-Xencor
-ZIOPHARM Oncology
Market driver
-Special regulatory designations
-For a full, detailed list, view our report
Market challenge
-High cost of therapy
-For a full, detailed list, view our report
Market trend
-Rise in development of combination therapies
-For a full, detailed list, view our report
Key questions answered in this report
-What will the market size be in 2020 and what will the growth rate be?
-What are the key Market trends?
-What is driving this market?
-What are the challenges to market growth?
-Who are the Key vendors in this market space?
-What are the market opportunities and threats faced by the Key vendors?
-What are the strengths and weaknesses of the Key vendors ?
You can request one free hour of our analyst's time when you purchase this market report. Details are
provided within the report.
Request A Sample copy of This Report @ http://www.hexareports.com/sample/132310
Table of Contents
PART 01: Executive summary
-Highlights
PART 02: Scope of the report
Hexa Reports
Market Research Reports and Insightful Company Profiles
-Market overview
-Top-vendor offerings
PART 03: Market research methodology
-Research methodology
-Economic indicators
PART 04: Introduction
-Key market highlights
PART 05: Disease overview
-Understanding the disease
-Types of CLL
-Symptoms
-Diagnosis
-Staging
-Management
-Key buying criteria
PART 06: Pipeline analysis
-Acalabrutinib
-TG-1101 + ibrutinib
-TGR-1202
-Venetoclax + obinutuzumab
-Venetoclax + rituximab
-REVLIMID
-Duvelisib
PART 07: Market landscape
-Global CLL therapeutics market
-Total addressable market for global CLL therapeutics
-Five forces analysis
PART 08: Market segmentation by ROA
-Oral
-Parenteral
PART 09: Market segmentation by type of molecule
-Small molecules
-Biologics
Browse Full Report @ http://www.hexareports.com/report/global-chronic-lymphocytic-leukemiamarket-2016-2020/details
Hexa Reports
Market Research Reports and Insightful Company Profiles
About Us:
Hexa Reports is a market research and consulting organization, offering industry reports, custom
research and consulting services to a host of key industries across the globe. We offer comprehensive
business intelligence in the form of industry reports which help our clients obtain clarity about their
business environment and enable them to undertake strategic growth initiatives.
Contact Information:
Ryan Shaw
Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
United States
Phone Number
1-800-489-3075
Email Us: [email protected]
Our Website: http://www.hexareports.com/
Visit Our Blogs: http://hexareports.blogspot.in
Author
beltranbob87
beltranbob87328   documents Email
Document
Category
Health and Medicine
Views
6
File Size
426 KB
Tags
size
1/--pages
Report inappropriate content